Downregulation of ROS1 enhances the therapeutic efficacy of arsenic trioxide in acute myeloid leukemia cell lines
2015 ◽
Vol 102
(1)
◽
pp. 12-24
◽
2009 ◽
2017 ◽
Vol 9
(11)
◽
pp. 1213-1225
◽
2010 ◽